Author： Alessandro Dario Giustino Tomei
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.27, Iss.11, 2004-01, pp. : 799-818
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Botulinum Toxin Treatment of Adult Spasticity: A Benefit-Risk Assessment
Drug Safety, Vol. 29, Iss. 1, 2006-01 ,pp. :
Access to resources
Recommend
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :
A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
By Cahill Kate Stead Lindsay Lancaster Tim
Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. :
Benefit-Risk Assessment of Treatments for Heparin-Induced Thrombocytopenia
Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. :